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Abstract
Objective: To evaluate the feasibility of implementing an integrated multicomponent survivorship care model for men affected by prostate cancer.
Methods: Using a single arm prospective cohort study design, men with prostate

Funding information
Movember

cancer were recruited from two regional public hospitals in Australia for a 6‐months
program that provided information and decision support, exercise and nutrition

[Correction added on 16-Aug-2021, after first
online publication: The order of section level
headings for 2.4 and 2.5 has been updated.]

management, specialised clinical support, and practical support through localised
and central care coordination. Carers of the men were also invited to the program.
Data were collected from multiple sources to evaluate: (1) recruitment capability
and participant characteristics; (2) appropriateness and feasibility of delivering the
specific intervention components using an electronic care management tool; and (3)
suitability of data collection procedures and proposed outcome measures.
Results: Of the 105 eligible men, 51 (consent rate 49%) participated in the program.
Of the 31 carers nominated by the men, 13 consented (consent rate 42%). All carers
and 50 (98%) men completed the program. Most (92%) men were newly diagnosed

-
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with localised prostate cancer. All men attended initial screening and assessment for
supportive care needs; a total of 838 episodes of contact/consultation were made by
the intervention team either in person (9%) or remotely (91%). The intervention was
implemented as proposed with no adverse events. The proposed outcome measures
and evaluation procedures were found to be appropriate.
Conclusions: Our results support the feasibility of implementing this integrated
multicomponent care model for men affected by prostate cancer.
KEYWORDS

cancer, feasibility, model of care, oncology, psycho‐oncology, prostate, quality of life,
survivorship, urology

1 | INTRODUCTION

couple‐based interventions also report benefits for carers, such as

Approximately 20,000 men are diagnosed with prostate cancer each

adjustment to the disease.14,18

improved information and psychosocial support, better coping and
year in Australia and 95% of them live at least 5 years after diagnosis.1

While evidence for prostate cancer survivorship care in-

The prostate cancer survivorship starts at the time of initial diagnosis

terventions has grown over the last decade, most studies to date

and treatment and remains the rest of life,2 in which men face various

have focused on one area of care, with single intervention ap-

challenges associated with complex treatment decisions, treatment‐

proaches that report only on the short‐term effects. These studies

related side effects, psychological distress and the prospect of recur-

often fail to recognise that many men and their carers have multiple

rence or progression of disease. Urinary incontinence and erectile

supportive care needs that can exist over extended periods of time.2

dysfunction are the most common treatment‐related side effects

It is noteworthy to mention that the design and implementation for

following radical prostatectomy that negatively impact quality of life.

long‐term comprehensive survivorship interventions are sometimes

Other common treatment‐related side effects include bowel urgency

restrained due to issues such as short funding periods and privately

from radiation therapy, and deterioration in body composition, phys-

insured health care systems.

ical function, cardiometabolic toxicity and loss of libido and physical
3–6

Recent literature highlights the need to develop comprehensive

Additionally, men

models of survivorship care that recognise the multiple co‐existing and

can experience acceleration of comorbid conditions associated with

changing requirements that men with prostate cancer experience, and

their cancer treatment, such as osteopenia and osteoporosis, cardio-

the many service providers that need to be engaged to prevent and

vascular disease, diabetes and obesity.6 The complexity of these dis-

manage these needs over time.2 In Australia, the recent Prostate

ease‐ and treatment‐related effects mean that many men with

Cancer

prostate cancer are at risk of or experience unmet supportive care

coordinated and responsive survivorship care, in which an inte-

feminisation from androgen deprivation therapy.

Survivorship

Essentials

Framework19

supports

well‐

needs. Carers of these men report unmet needs in relation to infor-

grated, needs‐based approach to survivorship care is required. This

mation and health care services,7 with some studies reporting that

includes a tailored approach to address the complexity of each in-

carers can experience greater distress than the men.8,9

dividual’s requirements through multi‐faceted health care, including

To promote comprehensive follow‐up care and improve quality life

psychological, exercise and nutrition support.20 While the principles

of men with prostate cancer, the American Cancer Society (ACS) and

inherent in these models have become widely accepted, there is limited

American Society of Clinical Oncology (ASCO) Prostate Cancer Sur-

literature that reports on the development, implementation and eval-

10,11

vivorship Care Guidelines

identify five key domains for action:

uation of integrated multi‐component survivorship interventions.

health promotion, surveillance, physical side effects, psychosocial

This paper reports the outcomes of a study that assessed the

management, and care coordination. A number of studies have con-

feasibility of an integrated multi‐component survivorship intervention

ducted interventions to address these key areas of care. Exercise and

(known as TrueNTH, funded by Movember) designed for men with

psychosocial interventions have been shown to improve men’s health

prostate cancer and their partners/carers. Specifically, the aims of this

promotion and psychosocial outcomes and reduce physical side ef-

study were to evaluate: (1) recruitment capability and resulting

fects.12–14 Supported self‐management interventions have been

participant characteristics; (2) appropriateness and feasibility of

shown to be comparable to traditional follow‐up care15 and enhance

delivering the specific intervention components and using an elec-

sexual and urinary function.16 Nutrition interventions,17 with or

tronic care management tool to support delivery of the intervention;

without aerobic exercise, are efficacious in reducing body mass in

and (3) suitability of data collection procedures and proposed outcome

overweight and obese men with prostate cancer. Studies of family/

measures to obtain valid, reliable and complete data over time.
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be: (1) aged 18 years or older; (2) competent to give informed consent; and (3) able to complete questionnaires. Participation of the

2.1 | Study design

partner/carer was not a requirement for the man to participate in the
study.

This was a single arm prospective cohort study. The study was
registered with the Australian New Zealand Clinical Trials Registry
(ACTRN12615000499583) and received ethical approvals from the

2.3 | Intervention

lead universities (QUT Approval Number 1400000860) and participating health services.

The TrueNTH intervention was a multi‐component integrated model
of care for men with prostate cancer. Components of the program
and care pathway are illustrated in Figure 1. An experienced urology

2.2 | Setting and sample

nurse with demonstrated capabilities in clinical assessment and care
planning, supportive care, advanced communication, teamwork, and

Based on the capacity and readiness to implement the intervention,

organisational skills was based at each site to coordinate the health

two regional public health services from Queensland and New South

care needs of the participant. This nurse was nominated to be

Wales were selected to participate. Men were eligible if they: (1) were

the local care coordinator responsible to deliver or facilitate the

diagnosed with localised prostate cancer within the last 3 months or

intervention components for approximately three months via face‐

diagnosed with advanced prostate cancer at least 12 months prior to

to‐face consultation, video or telephone support, or email

the recruitment period; (2) were able and willing to participate in the

communication.

intervention and complete patient reported outcome assessments;

After three‐months, men who were on active surveillance or had

and (3) nominated a general practitioner (GP) who agreed to use an

completed treatment and no longer required for specialised treat-

online care management tool. Men were excluded from the study if

ment service (i.e., surgery, radiation) were referred to a Movember

they: (1) were too unwell (as determined by their treating specialists);

employed central care coordinator who was independent to the

or (2) had physical, psychological or cognitive difficulties that would

participating sites. The central care coordinator provided ongoing

prevent them from participating in the intervention or completing

information and support on an as needed basis and facilitated

self‐report outcome measures. The treating specialist (e.g., urologist,

referral to relevant clinical or supportive care services to meet

radiation or medical oncologist) introduced the study to the potential

ongoing and newly emergent needs of men using telephone or video

participants when they attended clinic appointments at the site. Men

conferencing support as required.

who expressed interest were referred to an on‐site research nurse

At enrolment, all men received a structured face‐to‐face

(who operated independently from nurses delivering the intervention)

consultation with the local care coordinator who comprehensively

for further study information and written consent. Upon consenting,

assessed their needs related to prostate health, general and psy-

men were asked to nominate a GP who was subsequently sent written

chological health, nutritional status, and supportive care needs. Men

information about the study. Verbal consent to participate was ob-

were provided with an evidence‐based education package relevant

tained from the GP via a follow‐up telephone conversation with the

to their stage of disease and treatment and decision support material

research nurse.

(e.g., the online P3P Decision Support Program21) if they were newly

All consented men were asked to nominate one partner/carer,

diagnosed with prostate cancer and not yet received treatment.

who was also invited to participate. Partners/carers were required to

Partners/carers were encouraged to attend the session with the man

F I G U R E 1 Components of the TrueNTH
program and care pathway for men with
prostate cancer
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and were provided with support as appropriate, which included the

These measures were documented by the research nurse responsible

provision of relevant information.

for recruitment using structured forms.

The outcome of the initial assessment was communicated to the
man’s treating specialist/team and GP via email or postal mail. This
information was used as the basis for development of a care plan and
referral to appropriate specialist support services according to the

2.4.2 | Appropriateness and feasibility of delivering
intervention components

man’s health needs and preferences, preference of treating
specialist/team and the availability of local resources. The local care

Information on intervention delivery and attendance were captured by

coordinator liaised with the man’s GP to facilitate additional as-

cdmNet. After each initial consultation, the local care coordinators also

sessments for risks or comorbidities. Based on the assessment, the

completed a log to record the extent to which they delivered inter-

GP liaised with the treating team to facilitate the management of any

vention activities and the length of the session. Seven sessions were

identified risk factors and conditions.

audio‐recorded with permission from the participants to enable

All men were referred to an accredited exercise physiologist and

assessment of the fidelity of the intervention delivery to protocol.

an accredited practising dietitian either locally or through a centralised service to receive an evidence‐based exercise prescription
and individualised dietetic services, respectively. They were provided
with information about local peer support programs and were

2.4.3 | Suitability of data collection procedures and
proposed outcome measures

referred to relevant support services to address their needs relating
to transport, accommodation, finance, legal, employment and respite
services for carers, as required.

Surveys were conducted with participants at enrolment (T0), and at 3
months (T1) and 6 months (T2) after enrolment. A range of validated

The above services were offered to all men regardless their stage

questionnaires (Appendix S1) was used to measure patient‐reported

of prostate cancer and treatment received. The needs for specific

health outcomes, including prostate cancer‐specific quality of life

prostate cancer related services (as shown in Figure 1) varied by men’s

(EPIC‐26),22 psychological well‐being (GHQ‐12),23,24 experience of

stage of disease and treatment received and thereby the specialised

care (PPE‐15),25 supportive care needs (SCNS‐SF34),26 and deci-

services were by referral at any point during the intervention according

sional conflict27/regret.28 The proposed economic outcome mea-

to needs. These services were delivered locally where available or

sures, including three health‐related quality of life measures (i.e., EQ‐

remotely by a central specialist service engaged for the purposes of this

5D‐5L,29 AQoL‐8D30 and FACT‐P31), self‐reported health service

project. Not all men needed all specialised services.

usage and cost data were also collected via the survey. The T0 survey

To ensure the intervention fidelity, a detailed intervention

was completed by participants at the clinic on the day of the initial

manual was provided to the care coordinators. All staff involved in

consultation and follow‐up questionnaires were posted to the par-

the intervention delivery attended an orientation and skill devel-

ticipants with pre‐paid return envelopes. The research nurse would

opment program, ongoing education and training as required, and

aid participants if required. Participants were informed that their

regular team meetings. An online care management tool (cdmNet1)

responses were confidential and not supplied to their care providers.

was used to manage and support care planning, delivery, and review
of the services by the intervention team. Men were provided with
this tool at the initial consultation, which enabled them to access

2.5 | Data analysis

the individualised care plan and undertake ongoing self‐monitoring
of their symptoms and needs on a 3 monthly basis or when new

All quantitative analyses were performed using SPSS for Windows

symptoms emerged. An alert was sent to the local care coordinator

(Version 23.0). Descriptive statistics were used to summarise data

and GP when assessments were completed. If the man did not want

relating to the primary feasibility outcomes (i.e., recruitment, reten-

to use cdmNet to communicate with the care team or access in-

tion, characteristics of participants) and the uptake of the interven-

formation, hard copies of information and the care plan were pro-

tion components. The tape recordings of the initial consultation

vided with telephone support.

sessions were reviewed using a checklist that included key intervention components to describe what topics were addressed and to
what extent.

2.4 | Data collection and measurements

While the study was not powered to assess clinical significance,
one‐way ANOVA was employed to undertake exploratory compar-

2.4.1 | Recruitment capability and resulting
participant characteristics

isons on the proposed outcome measures over the study period.
Only

participants

who

provided

data

at

all

three

time

points were included in the test. An alpha level of p ≤ 0.05 was
The primary outcome for this study was feasibility measured by the

considered statistically significant. The internal consistency of these

number of eligible patients in the targeted population, number of

outcome measures was estimated by using Cronbach’s alpha

consents, reasons for declining participation, and retention rate.

coefficient with a level of 0.70 considered suitable.
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the intervention were addressed in these sessions is reported in
Appendix S2. During the session, information and education com-

3.1 | Recruitment capability and participant
characteristics

ponents of the intervention were explained to the men in great detail.
For approximately one in five men, intervention components relating
to decision support and technology supported monitoring were

During the recruitment period between 2015 and 2016 (one site

addressed a little or not at all. Referrals to sexual counselling,

recruited for 6 months and another site recruited for 12 months), a

continence and psychological services were addressed to a lesser

total of 183 men with prostate cancer were referred to the study (see

extent than other support services. The average length of the session

Figure 2). Of the 105 eligible men, 51 consented (consent rate 49%);

was 141 min (SD = 33). The coordinators also spent on average

of the 31 nominated carers, 13 consented (consent rate 42%).

134 min (SD = 41) organising and/or following‐up the session.

Baseline demographic characteristics of participants are presented in

Partners/carers were present at 67% of the sessions (n = 34); and of

Table 1. Most men (n = 47, 92%) were newly diagnosed with localised

these partners/carers, 89% (n = 30) were involved completely or to a

prostate cancer at enrolment; among them 70% (n = 33) received

great extent in the sessions. Excluding the initial consultation, local

surgery, 13% (n = 6) received radiotherapy, 6% (n = 3) received

care coordinators made a total of 350 episodes of contact/consul-

multiple treatments, and 11% (n = 5) were undergoing active sur-

tation with the men to provide ongoing monitoring and support; and

veillance during the study. Of the four men with advanced prostate

the average length of each contact/consultation was 16 min

cancer, three were undergoing hormone treatment and one had

(SD = 16).

completed surgery at enrolment.

3.2 | Intervention delivery

3.2.2 | Number and delivery mode of intervention
components

3.2.1 | Local care coordinator interventions

A total of 838 episodes of contact/consultation were made with the
intervention team, including 401 contacts made by the local care

All men attended the initial consultation with the local care co-

coordinators, 80 by the central care coordinators, 180 by dietitians,

ordinators at enrolment. The themes identified from these sessions

122 by exercise physiologists, 53 by psychiatrists, one by a sexual

are presented in Table 2. The extent to which various components of

health specialist and one by a continence consultant. Each man

FIGURE 2
procedure

Flow diagram of the study
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Characteristics of participants at baseline (51 men and 13 partners/carers)

Characteristics

Men

Partners/Carers

Age (years)

Mean 62.9 (SD = 6.9, range 49–76)

Mean 58.5 (SD = 7.6, range 46–69)

n (%)

n (%)

Age groups (years)

Area of residence

Marital status

Education level

40–49

1 (2)

2 (15)

50–59

15 (29)

3 (23)

60–69

28 (55)

8 (62)

70–79

7 (14)

00 (0)

Major cities

11 (22)

00 (0)

Inner regional

39 (77)

12 (92)

Outer regional

1 (2)

1 (8)

Remote

00 (0)

00 (0)

Very remote

00 (0)

00 (0)

Married/de facto

38 (75)

12 (100)

Widowed

1 (2)

00 (0)

Divorced/separated

9 (18)

00 (0)

Never married

3 (6)

00 (0)

No formal schooling/Primary school

2 (4)

00 (0)

Secondary school
Trade apprenticeship
TAFE college
University degree or higher

Employment status

Annual gross income (individual)

Being a carer to dependents

00 (0)

11 (22)

3 (23)

9 (18)

4 (31)

00 (0)

2 (15)

Working full/part‐time

21 (41)

7 (54)

Retired

22 (43)

5 (38)

Home duties

00 (0)

1 (8)

Unemployed

7 (14)

00 (0)

Sick/on leave/disability

1 (2)

00 (0)

< $20,000

16 (31)

5 (42)

$20,000‐$39,999

11 (22)

1 (8)

$40,000‐$59,999

10 (20)

1 (8)

$60,000‐&79,999

7 (14)

3 (25)

≥ $80,000

2 (4)

No information provided

5 (10)

2 (17)

10 (20)

1 (8)

Aged spouse/relative/friend

1 (2)

2 (17)

Person with a disability

2 (4)

No dependents
Other
Health concession card holder

8 (16)

4 (31)

Other

Dependent child

a

21 (41)

37 (72)
1 (2)
29 (58)

00 (0)

00 (0)
9 (75)
00 (0)
6 (46)

(Continues)
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T A B L E 1 (Continued)
Characteristics
b

Eligible for IPTAA)

Willingness to provide consent for collection of medicare data

c

Men

Partners/Carers

15 (33)

Not applicable

49 (96)

13 (100)

Abbreviations: IPTAAS, isolated patients travel & accommodation assistance scheme; SD, standard deviation.
a

For people on a low income or who have reached qualifying age for Age Pension to access to Pharmaceutical Benefits Scheme prescription items, and
certain Medicare services, at a cheaper rate.

b

IPTAAS is a subsidy program which provides financial assistance to help with travel and accommodation costs for people who need to travel long
distances to access specialist medical services not available locally.

c

Medicare data are health related statistics administered by the Australian government which provide information on general practitioner, specialist,
diagnostic test and prescription pharmaceutical use.

TABLE 2

Topics addressed by local care coordinators in initial consultations

Themes

Examples

Screening and assessment

� Assessment of prostate cancer specific symptoms, distress and nutrition screening using
the tools as per protocol.
� Assessment of prostate cancer stage, treatments received or treatment intention,
medication, and comorbidities.

Navigation and referral

� Informing men about the TrueNTH program and central care coordination, e.g., what
support and services would be available, who would contact the man and how the
services would be delivered; role of the general practitioner (GP); communication between care coordinators, treating specialists and other care providers.
� Introduction of care plan and multidisciplinary approach.

Information provision and education

� Introduction of reliable online information resources and provision of TrueNTH education package, e.g., (PCFA), Andrology Australia, cancer Council online fact sheets and
booklets.
� Explanation about stage of disease, treatment options, prognosis, and test results etc.
� Discussion of post treatment issues, such as side effects of treatment on sexual function
and penile rehabilitation, continence; activities that enhance the recovery.

Decision support

� Introduction of the personal patient profile (P3P).

Self‐management support

� Providing access to and demonstrating the use of cdmNet.

Practical and peer support

� Introduction of local prostate cancer support groups.
� Discussion of financial issues related to cancer treatment.
� Discussion of carer and family support.

Advanced prostate cancer comorbidities management � Explanation about the role of GP.
� Introduction of the exercise and nutrition components of the TrueNTH program.

Note: Based on the recordings of seven initial consultation sessions.
Abbreviation: PCFA, prostate cancer Foundation of Australia.

received a median of 16 contacts. Approximately 9% of the contacts

experienced or reported by participants as a result of the

were conducted in person, 76% were made via phone, and 15% via

intervention.

email or online teleconference or other modes.

3.2.4 | Use of technology
3.2.3 | Completion rates
Data captured by cdmNet showed that it was used for supporting the
Nearly all men (98%) and all carers completed the full 6‐months

delivery of the intervention in a variety of ways. The local care co-

intervention, with only one man withdrawing after two months

ordinators used it to assess key patient‐reported outcomes (i.e.,

due to personal and family issues. No adverse health events were

prostate cancer specific symptoms, distress level and initial nutrition
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Australia. Our findings are that the program was accepted by men,

vices. The intervention team used it for communication and to

was largely implemented as per protocol with high completion rates

manage and support care planning, care delivery and review. There

and no adverse events. The proposed evaluation procedures were

was no record that the tool was used by referring specialists or by

appropriate. However, some important issues were raised in this

GPs. Men’s progress was updated with their specialists and GPs via

study that have implications for future studies involving multicom-

telephone conversations, emails or letters prepared by care

ponent interventions.

coordinators.

Interest in the program by the treating team was high and use
of existing clinical networks as referral sources was effective. Over
180 referrals were received from the two regional settings during

3.3 | Data collection procedures and outcome
measures

the recruitment period. Of note, around 40% of the referrals did
not meet the inclusion criteria relating to time since diagnosis. The
strict inclusion criteria in the present study were chosen to enhance

All participants completed T0 survey, 35 men and 12 partners/carers

homogeneity of the sample and enable testing of the full inter-

returned T1, and 36 men and all partners/carers returned T2 survey.

vention pathway from the beginning of their cancer journey. The

Participants appeared to have no difficulty completing the health‐

high number of ineligible referrals due to duration of diagnosis

related outcome measures independently as there was little

highlights the clinician’s and/or the man’s desire to access sup-

missing data (<3%). The internal consistency reliability of these

portive care.

measures (as shown in Appendix S3) was satisfactory (Cronbach’s

The main reason that eligible men declined participation in this

α = 0.67‐0.96), except for the urinary obstructive subscale (Cron-

study was ‘lack of interest’ or ‘not being in need of supportive care’

bach’s α = 0.51) of the EPIC questionnaire.

(50%), ‘feeling overwhelmed/perceived burden’ (20%) and ‘no desire

Some participants needed assistance from the research assistant

to use computers or smart devices’ (17%). Such concerns highlight

to complete the health service usage questionnaire as they had dif-

the need for active strategies to enhance men’s participation in the

ficulty spelling drug names, recalling all of the services and medicines

program, such as providing additional written information to explain

used, and the relevant costs over the preceding three months. As a

the purpose and procedures of the program, as well as possible

result, 2% of men and 5% of partner/carer responses were missing on

benefits and risks; offering hands‐on support for using computers/

the health services usage questions. However, men often provided

smart devices; and offering alternative modes of service and

more data regarding their use of pharmaceuticals than was reques-

communication. Post Covid‐19 pandemic it is likely that the ‘no

ted. In addition, 96% men and all partners/carers indicated a will-

desire to use computers or smart devices’ sentiment will be much

ingness to consent to the researchers accessing their Medicare data

reduced since all age groups of Australians have embraced computer‐

for health services usage data. The three health‐related quality of life

based forms of communication in much greater numbers than

measures (i.e. EQ‐5D‐5L, AQoL‐8D and FACT‐P) showed high

previously.

completion rates (missing data <2%).

The recruitment resulted in a sample of men who were of a

Scores from key patient‐reported health outcome measures

similar age range to men affected by prostate cancer in Australia.1

collected at each time point are summarised in Appendix S3. Symp-

Most men were from a regional area and one third of them had to

tom severity was highest for sexual dysfunction at all time points.

travel long distances (eligible for government subsidy) for treatment

Men reported a significant improvement regarding urinary obstruc-

and specialist appointments. Around 40% took time off work to

tion(p = 0.03), but worse sexual health (p < 0.001) and urinary in-

participate in the face‐to‐face services. Therefore, interventions that

continence (p < 0.01) over time. Levels of psychological distress in

are delivered remotely via telephone or digital health were appro-

men did not change (p = 0.73) over time with 57% (n = 29) at T0, 54%

priate and acceptable for the current sample. We suggest that while

(n = 19) at T1 and 63% (n = 22) at T2 reporting that they did not have

some men were reluctant to participate in the study due to concerns

any psychological distress. Around 18% of the men (n = 6) at T1 and

about use of technology, most intervention activities (91%) were

27% (n = 9) at T2 reported that they did not experience any problems

carried out remotely via telephone or digital health.

with their care. However, this change was not statistically significant

In terms of the data collection procedures and outcome mea-

(p = 0.30). There were no statistically significant changes over time in

sures, participants had no difficulty independently completing

terms of supportive care needs (p = 0.06‐0.64) and decision regret

questions related to their health and responded with minimal

(p = 0.39) for men.

missing data. The internal consistency of the key patient‐reported
health outcome measures with our sample was similar to that reported in the previous studies. The four quality of life measures that

4 | DISCUSSION

were tested in the study showed equally high acceptability and

This study assessed the feasibility of implementing an integrated,

35 and 40 items respectively, one contains 26 items (EPIC‐26), and

multicomponent care model designed to address critical areas of care

one (EQ‐5D‐5L) contains 5 items. The measures with most concise

for men and their partners/carers affected by prostate cancer in

items would be more acceptable for the larger trial. The advantage

response rates over time. Two of them (AQoL‐8D, FACT‐P) contain
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of the EQ‐5D‐5L and the AQoL‐8D is that generic health utility

service providers and settings are key to the successful management

scores can be generated for comparative economic evaluation

of patient care.

purposes (i.e., both instruments are multi‐attribute utility instruments (MAUIs) usable in a variety of settings).32 The AQoL‐8D
has more sensitivity to change than the EQ‐5D‐5L but is consid-

4.2 | Study limitations

erably longer. Both have been extensively used in trials to describe
the self‐rated health, but the EQ‐5D‐5L has had greater application

This study was designed to assess the feasibility and acceptability,

in prostate cancer patients.33 As a result, the EQ‐5D‐5L would be

but not the effectiveness of the intervention. Nonetheless, some

recommended for a larger study as the preferred economic instru-

preliminary observations can be made regarding the validity and

ment. The two measures (FACT‐P and EPIC‐26) were tested as

sensitivity of the tools. The changes regarding prostate cancer spe-

patient relevant outcome measures and as the comparison cancer

cific quality of life, while not designed to be evaluated for statistical

specific quality of life measure for the generic economic in-

significance, were in line with other patient‐reported outcome

struments. On balance the two shorter quality of life measures

studies,4,5 in which urinary obstructive symptoms improved with

would be chosen for a larger study–the EPIC‐26 (disease specific)

treatment over the time. Urinary continence and sexual functioning

and the EQ‐5D‐5L (generic).

declined initially and improved with time after treatment. Other
limitations of the study include the use of convenience study sites
and that most patients were newly diagnosed and were undertaking

4.1 | Clinical implications

or had just finished their treatment. While not all men needed all
services provided by the intervention during the study period,

Overall, the uptake of intervention components was high, and the

participation in the study likely increased men’s knowledge of disease

intervention was implemented as proposed. This included uptake of

and treatment effects and promoted awareness of such support

the referral to remotely provided nutrition and exercise management

which could benefit these men in the long‐term. Moreover, while

services, and other support following treatment completion. Smaller

referral to specialist services for side‐effects of treatment such as

numbers of referrals were made to specialised services including

urinary and sexual function was not high, the use of experienced

sexual counselling, continence, and psychological services. These

nurses with expertise in these areas likely has important benefits as

lower referral rates could reflect that such referrals were seen to be

some men would prefer that such sensitive topics are addressed by

necessary only for severe cases or reflect reluctance on the part of

known health professionals.

local care coordinators to share care with others. It might also reflect
reluctance on the part of patients to accept help for these concerns.
A previous study34 of a nurse‐led prostate cancer survivorship ser-

5 | CONCLUSIONS

vice in UK reported that 22% of men who initially declined to attend
a supportive care program asked for a supportive care clinic

In this study we have demonstrated the feasibility of implementing

appointment after attending education sessions. Our finding high-

an integrated multicomponent care model for men affected by

lights the need to develop clear protocols to facilitate needs‐based

prostate cancer. Future studies need to focus on how to engage with

referrals, and to actively work with patients to manage concerns

men and their partners/carers to ensure similar interventions take

about referrals to these services.

into account their concerns and to reduce burden. Consideration of

Partners/carers of the men were also actively involved in the

health literacy and tailoring of the intervention to personal circum-

program. Although only a quarter of partners/carers (13 out of 51)

stances are integral to success of long‐term interventions such as

participated in the study, two thirds of the initial consultation ses-

TrueNTH. Additional strategies to encourage the involvement of GPs,

sions (34 out of 51) included partners/carers and these sessions were

if they are to take on a more active role in follow up care, are needed.

well accepted.

Clear protocols that guide when referrals should be made to

We suggest that the online care management tool supported the
implementation of the intervention in multiple ways, including facil-

specialist support services will be required to ensure appropriate use
of these services.

itating the team communication. Even though the participating GPs
agreed to use the tool, none of them actually accessed it during the

A CK NO W L E DG E M EN T S

study, nor did the treating specialists. For this reason, the men’s

TrueNTH is funded by Movember, a global charity organisation

medical team received progress updates via telephone and letters

committed to the improvement of health outcomes for men living

written by care coordinators. It was also challenging to monitor and

with prostate cancer, as well as supporting men with testicular can-

obtain data on the services provided by the local service providers

cer and programmes focused on suicide prevention and mental

outside of the public health system. The barriers to using the tool for

health. NHH is supported by a Cancer Council of Western Australia

these health professionals need to be explored as effective commu-

Postdoctoral Research Fellowship. The authors would like to thank

nication within the patients’ care team and care coordination across
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